FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2755336301> ?p ?o ?g. }

• W2755336301 endingPage "98183" @default.
• W2755336301 startingPage "98163" @default.
• W2755336301 abstract "// Dongfeng Zhao 1, 2, 3, * , Chenglong Wang 1, 2, 4, * , Yongjian Zhao 1, 2, 3 , Bing Shu 1, 2, 3 , Youji Jia 1, 2 , Shufen Liu 1, 2, 3 , Hongshen Wang 1, 2, 3 , Junli Chang 1, 2, 3 , Weiwei Dai 1, 4 , Sheng Lu 1, 2 , Qi Shi 1, 2, 3 , Yanping Yang 1, 2, 3 , Yan Zhang 1, 2, 3 and Yongjun Wang 1, 2, 3, 5 1 Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, P.R. China 2 Spine Disease Research Institute, Shanghai University of Traditional Chinese Medicine, Shanghai, P.R China 3 Key Laboratory of Theory and Therapy of Muscles and Bones, Ministry of Education, Shanghai University of Traditional Chinese Medicine, Shanghai, P.R. China 4 Central Laboratory of Research, Longhua Hospital, Shanghai, P.R. China 5 School of Rehabilitation Science, Shanghai University of Traditional Chinese Medicine, Shanghai, P.R. China * These authors have contributed equally to this work Correspondence to: Yongjun Wang, email: yjwang8888@126.com Yan Zhang, email: medicineyan@aliyun.com Yanping Yang, email: yanpingyangks@163.com Keywords: cyclophosphamide; chemotherapy; osteoporosis; osteoblastogenesis; osteoclastogenesis Received: May 09, 2017     Accepted: August 23, 2017     Published: September 18, 2017 ABSTRACT The clinical evidence indicated that cyclophosphamide (CPD), one of the chemotherapy drugs, caused severe deteriorations in bones of cancer patients. However, the exact mechanisms by which CPD exerts effects on bone remodeling is not yet fully elucidated. Therefore, this study was performed to investigate the role and potential mechanism of CPD in osteoblastogenesis and osteoclastogenesis. Here it was found that CPD treatment (100mg/kg/day) for 7 days led to osteoporosis phenotype in male mice. CPD inhibited osteoblastogenesis as shown by decreasing the number and differentiation of bone mesenchymal stem cells (MSCs) and reducing the formation and activity of osteoblasts. Moreover, CPD suppressed the osteoclastogenesis mediated by receptor activator for nuclear factor-κ B ligand (RANKL) as shown by reducing the maturation and activity of osteoclasts. At the molecular level, CPD exerted inhibitory effect on the expression of components (Cyclin D1, β-catenin, Wnt 1, Wnt10b) of Wnt/β-catenin signaling pathway in MSCs and osteoblasts-specific factors (alkaline phosphatase, Runx2, and osteocalcin). CPD also down-regulated the expression of the components (tumor necrosis factor receptor-associated factor 6, nuclear factor of activated T-cells cytoplasm 1, c-Fos and NF-κB) of RANKL signaling pathway and the factors (matrix metalloproteinase 9, cathepsin K, tartrate-resistant acid phosphates and carbonic anhydrase II) for osteoclastic activity. Taken together, this study demonstrated that the short-term treatment of CPD induced osteoporosis in mice and the underlying mechanism might be attributed to its marked suppression on osteoblastogenesis and osteoclastogenesis, especially the effect of CPD on bone formation might play a dominant role in its detrimental effects on bone remodeling." @default.
• W2755336301 created "2017-09-25" @default.
• W2755336301 creator A5000005088 @default.
• W2755336301 creator A5005724526 @default.
• W2755336301 creator A5013414619 @default.
• W2755336301 creator A5014088164 @default.
• W2755336301 creator A5031184396 @default.
• W2755336301 creator A5032397876 @default.
• W2755336301 creator A5053329904 @default.
• W2755336301 creator A5055286127 @default.
• W2755336301 creator A5056079459 @default.
• W2755336301 creator A5065999911 @default.
• W2755336301 creator A5070434593 @default.
• W2755336301 creator A5074458519 @default.
• W2755336301 creator A5080284521 @default.
• W2755336301 creator A5086664284 @default.
• W2755336301 date "2017-09-18" @default.
• W2755336301 modified "2023-09-27" @default.
• W2755336301 title "Cyclophosphamide causes osteoporosis in C57BL/6 male mice: suppressive effects of cyclophosphamide on osteoblastogenesis and osteoclastogenesis" @default.
• W2755336301 cites W101295176 @default.
• W2755336301 cites W1218170828 @default.
• W2755336301 cites W1255151214 @default.
• W2755336301 cites W1506777188 @default.
• W2755336301 cites W1540658270 @default.
• W2755336301 cites W1592463652 @default.
• W2755336301 cites W1602216268 @default.
• W2755336301 cites W1761951195 @default.
• W2755336301 cites W1800396987 @default.
• W2755336301 cites W1863320839 @default.
• W2755336301 cites W1911356127 @default.
• W2755336301 cites W1948966592 @default.
• W2755336301 cites W1964726161 @default.
• W2755336301 cites W1975237975 @default.
• W2755336301 cites W1979545270 @default.
• W2755336301 cites W1981284961 @default.
• W2755336301 cites W1981622320 @default.
• W2755336301 cites W1984944369 @default.
• W2755336301 cites W1989362562 @default.
• W2755336301 cites W1993064864 @default.
• W2755336301 cites W1999369038 @default.
• W2755336301 cites W2001111734 @default.
• W2755336301 cites W2001209487 @default.
• W2755336301 cites W2003098906 @default.
• W2755336301 cites W2004190331 @default.
• W2755336301 cites W2007853662 @default.
• W2755336301 cites W2008531519 @default.
• W2755336301 cites W2013264023 @default.
• W2755336301 cites W2014007607 @default.
• W2755336301 cites W2016146691 @default.
• W2755336301 cites W2017372504 @default.
• W2755336301 cites W2018544354 @default.
• W2755336301 cites W2018810533 @default.
• W2755336301 cites W2040737693 @default.
• W2755336301 cites W2042171014 @default.
• W2755336301 cites W2042397391 @default.
• W2755336301 cites W2046627081 @default.
• W2755336301 cites W2048299560 @default.
• W2755336301 cites W2049557764 @default.
• W2755336301 cites W2053980056 @default.
• W2755336301 cites W2056712783 @default.
• W2755336301 cites W2064720410 @default.
• W2755336301 cites W2065297127 @default.
• W2755336301 cites W2066379687 @default.
• W2755336301 cites W2066749771 @default.
• W2755336301 cites W2067697372 @default.
• W2755336301 cites W2087755547 @default.
• W2755336301 cites W2088014747 @default.
• W2755336301 cites W2092114519 @default.
• W2755336301 cites W2093252878 @default.
• W2755336301 cites W2098474469 @default.
• W2755336301 cites W2102634320 @default.
• W2755336301 cites W2104298758 @default.
• W2755336301 cites W2105054202 @default.
• W2755336301 cites W2109050104 @default.
• W2755336301 cites W2113577242 @default.
• W2755336301 cites W2114935509 @default.
• W2755336301 cites W2117538544 @default.
• W2755336301 cites W2118817160 @default.
• W2755336301 cites W2119611611 @default.
• W2755336301 cites W2129526874 @default.
• W2755336301 cites W2138440511 @default.
• W2755336301 cites W2155072174 @default.
• W2755336301 cites W2155251261 @default.
• W2755336301 cites W2164356078 @default.
• W2755336301 cites W2164966638 @default.
• W2755336301 cites W2166266977 @default.
• W2755336301 cites W2167027232 @default.
• W2755336301 cites W2170965544 @default.
• W2755336301 cites W2187268904 @default.
• W2755336301 cites W2321321977 @default.
• W2755336301 cites W2398253505 @default.
• W2755336301 cites W2412364667 @default.
• W2755336301 cites W2414898542 @default.
• W2755336301 cites W2486233532 @default.
• W2755336301 cites W2514944617 @default.
• W2755336301 cites W2520561386 @default.
• W2755336301 cites W4232890539 @default.
• W2755336301 cites W49871344 @default.

• next